MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results

MiniMed (MMED) expects to report its fiscal year 2027 second-quarter financial results on November 24, 2026.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

MiniMed (MMED) expects to report its fiscal year 2027 second-quarter financial results on November 24, 2026. The quarter ended October 30, 2026. The financial news release is expected at approximately 3:45 a.m. PST, followed by a results webcast at 5:30 a.m. PST.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/04/2026 - 04:15 PM EST

NORTHRIDGE, Calif., Nov. 4, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24, 2026, for its second quarter of fiscal year 2027, which ended on Friday, October 30, 2026.

A news release containing summary financial information is expected at approximately 3:45 a.m. Pacific Standard Time (PST) and will be available at https://news.minimed.com.
A webcast discussing results is expected to be held at 5:30 a.m. PST, accessible at https://investors.minimed.com.
A replay of the webcast and transcript of the prepared remarks is expected to be available within 24 hours of the webcast by clicking on the Events link at https://investors.minimed.com.

About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.

Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-announce-its-fiscal-year-2027-second-quarter-financial-results-302928451.html